Related references
Note: Only part of the references are listed.Oligodendrocytes: Potential of Discovering New Treatment Targets
Caroline Brandao-Teles et al.
FRONTIERS IN PHARMACOLOGY (2019)
Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice
Kohei Takahashi et al.
NEUROPHARMACOLOGY (2019)
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
Antonio Vita et al.
FRONTIERS IN PHARMACOLOGY (2019)
NMDAR Hypofunction Animal Models of Schizophrenia
Gloria Lee et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
Shusuke Numata et al.
FRONTIERS IN PHARMACOLOGY (2018)
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine
Domenico De Berardis et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2018)
Phencyclidine administration during neurodevelopment alters network activity in prefrontal cortex and hippocampus in adult rats
Celia Kjaerby et al.
JOURNAL OF NEUROPHYSIOLOGY (2017)
30 Years on: How the Neurodevelopmental Hypothesis of Schizophrenia Morphed Into the Developmental Risk Factor Model of Psychosis
Robin M. Murray et al.
SCHIZOPHRENIA BULLETIN (2017)
Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia
Philip L. R. Gaskin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model
Felipe V. Gomes et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
John Lally et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2016)
Schizophrenia: a tale of two critical periods for prefrontal cortical development
L. D. Selemon et al.
TRANSLATIONAL PSYCHIATRY (2015)
Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia
Christina A. Wilson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat
Philip L. R. Gaskin et al.
PSYCHOPHARMACOLOGY (2014)
Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine
Marisa Moeller et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Executive Functioning in Schizophrenia
Gricel Orellana et al.
Frontiers in Psychiatry (2013)
5-HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
Julie Meffre et al.
EMBO MOLECULAR MEDICINE (2012)
Blockade of dopamine D3 but not D2 receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment
David J. G. Watson et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
A two-hit model: behavioural investigation of the effect of combined neonatal MK-801 administration and isolation rearing in the rat
Ann Li Lim et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Animal models of schizophrenia
C. A. Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Hyperactivity of the hypothalamus-pituitary-adrenal axis in lipopolysaccharide-induced neurodevelopmental model of schizophrenia in rats: Effects of antipsychotic drugs
Agnieszka Basta-Kaim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?
James M. Stone
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2011)
The environment and schizophrenia
Jim van Os et al.
NATURE (2010)
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
Joanna C. Neill et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis
Urs Meyer et al.
PSYCHOPHARMACOLOGY (2010)
Neonatal Phencyclidine Treatment in Mice Induces Behavioral, Histological and Neurochemical Abnormalities in Adulthood
Akiko Nakatani-Pawlak et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
The Neurodevelopmental Hypothesis of Schizophrenia, Revisited
S. Hossein Fatemi et al.
SCHIZOPHRENIA BULLETIN (2009)
Evaluation of a neurodevelopmental model of schizophrenia - Early postnatal PCP treatment in attentional set-shifting
Brian Villumsen Broberg et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
CATIE and CUtLASS: can we handle the truth?
Shon Lewis et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Behavioural and neurochemical effects of post-weaning social isolation in rodents - Relevance to developmental neuropsychiatric disorders
Kevin C. F. Fone et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
Atypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups
Noelle C. Anastasio et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment
Akihiro Mouri et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment
Silke Harich et al.
PSYCHOPHARMACOLOGY (2007)
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
Richard S. E. Keefe et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats
Bruce A. Rasmussen et al.
PSYCHOPHARMACOLOGY (2007)
Chronic administration of clozapine alleviates reversal-learning impairment in isolation-reared rats
Nanxin Li et al.
BEHAVIOURAL PHARMACOLOGY (2007)
Variations in the incidence of schizophrenia: Data versus dogma
JJ McGrath
SCHIZOPHRENIA BULLETIN (2006)
Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions
NA Addy et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine
JD Andersen et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: Implications for schizophrenia
C Wang et al.
NEUROSCIENCE (2001)
Share Paper
